Adding a dual GLP-1/GIP receptor agonist to the psoriasis drug ixekizumab (Taltz) significantly improved outcomes in adults ...

I've always been vigilant about monitoring my skin for unusual spots since I have a family history of melanoma in addition to ...

Tildrakizumab maintained efficacy and safety in obese patients with scalp psoriasis over 52 weeks. Find out more about the ...

Find Stroke Without Pain Latest News, Videos & Pictures on Stroke Without Pain and see latest updates, news, information from NDTV.COM. Explore more on Stroke Without Pain.

MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where ...

European Commission approves Bristol Myers Squibb’s Sotyktu for the treatment of active psoriatic arthritis in adults: Princeton, New Jersey Monday, May 11, 2026, 15:00 Hrs [IST ...

In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements in ...

The Met Gala steps have been witness to many viral looks, from Jared Leto carrying his own head to Kim Kardashian not even ...

MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where MoonLake and the FDA aligned on submission plans and the lab ...

Earnings call AbbVie delivered a strong Q1 2026, with adjusted EPS of $2.65 (+$0.07 vs guidance midpoint) and net revenues of $15B (+12.4% YoY), driven by robust growth in immunology and neuroscience.

NKTR looks de-risked after positive Rezpeg phase 2 data in atopic dermatitis & alopecia areata, with 80% upside and $1.1B ...

AbbVie today announced the presentation of new data across its gastroenterology portfolio at the 2026 Digestive Disease Week (DDW) Annual Meeting, May 2-5 in Chicago. AbbVie will present 18 abstracts, ...